These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 1731450
21. Late potentials on signal-averaged electrocardiograms and patency of the infarct-related artery in survivors of acute myocardial infarction. Vatterott PJ, Hammill SC, Bailey KR, Wiltgen CM, Gersh BJ. J Am Coll Cardiol; 1991 Feb; 17(2):330-7. PubMed ID: 1899434 [Abstract] [Full Text] [Related]
22. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. Baardman T, Hermens WT, Lenderink T, Molhoek GP, Grollier G, Pfisterer M, Simoons ML. Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377 [Abstract] [Full Text] [Related]
23. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial. Wackers FJ, Terrin ML, Kayden DS, Knatterud G, Forman S, Braunwald E, Zaret BL. J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246 [Abstract] [Full Text] [Related]
24. Use of creatine kinase isoforms for diagnosis of infarct artery patency after thrombolytic therapy with streptokinase. Norris RM, Twigden DG, Williams BF, Johnson RN, White HD. Coron Artery Dis; 1993 Feb; 4(2):201-5. PubMed ID: 8269212 [Abstract] [Full Text] [Related]
25. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. Al-Khatib SM, Stebbins AL, Califf RM, Lee KL, Granger CB, White HD, Armstrong PW, Topol EJ, Ohman EM, GUSTO-III trial. Am Heart J; 2003 Mar; 145(3):515-21. PubMed ID: 12660676 [Abstract] [Full Text] [Related]
26. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty. Bruna C, Rossetti G, Vado A, Racca E, Steffenino G, Dellavalle A, Ribichini F, Ferrero V, Menardi E, Uslenghi E. G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040 [Abstract] [Full Text] [Related]
27. Time course and characteristics of ventricular arrhythmias after reperfusion in acute myocardial infarction. Cercek B, Lew AS, Laramee P, Shah PK, Peter TC, Ganz W. Am J Cardiol; 1987 Aug 01; 60(4):214-8. PubMed ID: 2441585 [Abstract] [Full Text] [Related]
28. [Arrhythmia as an indicator for reperfusion following acute myocardial infarct?]. Langes K, Bleifeld W, Mathey DG, Kuck KH. Klin Wochenschr; 1989 Dec 04; 67(23):1199-204. PubMed ID: 2514318 [Abstract] [Full Text] [Related]
29. [Indirect criteria of coronary reperfusion and permeability in patients with acute myocardial infarction who have received thrombolytic therapy]. Pereira MA, Albuquerque A, Azevedo JG, Torres S, Gomes L, Campos M, Pimenta A. Rev Port Cardiol; 1991 Mar 04; 10(3):229-35. PubMed ID: 1854515 [Abstract] [Full Text] [Related]
30. The effect of thrombolytic therapy on QT dispersion in acute myocardial infarction and its role in the prediction of reperfusion arrhythmias. Ornek E, Duran M, Ornek D, Demirçelik BM, Murat S, Kurtul A, Çiçekçioğlu H, Çetin M, Kahveci K, Doger C, Çetin Z. Niger J Clin Pract; 2014 Mar 04; 17(2):183-7. PubMed ID: 24553029 [Abstract] [Full Text] [Related]
31. Ventricular arrhythmias during reperfusion. Miller FC, Krucoff MW, Satler LF, Green CE, Fletcher RD, Del Negro AA, Pearle DL, Kent KM, Rackley CE. Am Heart J; 1986 Nov 04; 112(5):928-32. PubMed ID: 3776819 [Abstract] [Full Text] [Related]
32. Thrombolysis-related early patency reduces ECG late potentials after acute myocardial infarction. Moreno FL, Karagounis L, Marshall H, Menlove RL, Ipsen S, Anderson JL. Am Heart J; 1992 Sep 04; 124(3):557-64. PubMed ID: 1514481 [Abstract] [Full Text] [Related]
33. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. Berger PB, Ruocco NA, Ryan TJ, Frederick MM, Podrid PJ. J Am Coll Cardiol; 1993 Dec 04; 22(7):1773-9. PubMed ID: 8245327 [Abstract] [Full Text] [Related]
34. Electrically induced ventricular arrhythmias in acute myocardial infarction treated with thrombolytic agents. McComb JM, Gold HK, Leinbach RC, Newell JB, Ruskin JN, Garan H. Am J Cardiol; 1988 Aug 01; 62(4):186-91. PubMed ID: 3135738 [Abstract] [Full Text] [Related]
35. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery. Dwivedi SK, Saran RK, Narain VS, Bansal S, Gupta R, Puri VK. Indian Heart J; 2000 Aug 01; 52(1):40-4. PubMed ID: 10820932 [Abstract] [Full Text] [Related]
36. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. Hohnloser SH, Zabel M, Kasper W, Meinertz T, Just H. J Am Coll Cardiol; 1991 Jul 01; 18(1):44-9. PubMed ID: 2050939 [Abstract] [Full Text] [Related]
37. Multivariate associates of QT dispersion in patients with acute myocardial infarction: primacy of patency status of the infarct-related artery. TEAM-3 Investigators. Third trial of Thrombolysis with Eminase in Acute Myocardial Infarction. Karagounis LA, Anderson JL, Moreno FL, Sorensen SG. Am Heart J; 1998 Jun 01; 135(6 Pt 1):1027-35. PubMed ID: 9630107 [Abstract] [Full Text] [Related]
39. Value of signal averaged electrocardiogram for prediction of successful coronary artery thrombolysis. Stajer D, Rode P. Cor Vasa; 1991 Jun 01; 33(1):11-8. PubMed ID: 1914464 [Abstract] [Full Text] [Related]